SCM wins award for Outstanding Growth

UK CDMO has almost doubled in size during 2011

UK sterile filling specialist SCM Pharma has been named winner of the Outstanding Growth Award at the Cels Business for Life Awards 2011.

The development and contract manufacturing organisation (CDMO) secured the award at an awards evening in North East England after almost doubling in size over the last 12 months.

As a result of this expansion, the firm has been able to recruit more staff and acquire a new facility at the University of Sunderland’s Science Complex as part of the launch of its in-house formulation development service.

This achievement follows the firm’s success last year at the same event where it won the Export Award, a category for which SCM Pharma was also named as a finalist once again this year.

Dianne Sharp, managing director at SCM Pharma, said: ‘This achievement reflects the hard work, dedication and drive of every person in our business. As you'd expect from SCM Pharma, we will not be resting on our laurels and are already looking at building on this solid foundation.’

The Business for Life Awards, which are now in their fifth year, are hosted by Cels, a specialist organisation based in Newcastle-upon-Tyne that provides support and commercial services to healthcare and life science companies.

You may also like

Manufacturing

Shire buys assets of SCM Pharma

Confirms that 80 jobs are safeguarded at Northumberland-based company
You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing

HAPI capacity reaches an all-time high

While today’s drugs are more targeted and effective, they bring with them production issues of sterility and higher potency. Susan Birks reports on how the contract manufacturing market has responded to the growing demand for specialist high potency and sterile services
You need to be a subscriber to read this article.
Click here to find out more.
Containment

Handle with care – high potency APIs

Contract manufacturer SCM Pharma, which handles small volume runs of cytotoxic powders and liquids for several clients, outlines the basic containment and cleaning requirements for ensuring worker safety and product purity
Manufacturing

SCM\'s Prudhoe facility gains FDA approval

UK CDMO supports BTG for commercial launch of varicose veins treatment
Manufacturing

SCM Pharma gains MHRA approval for commercial facility

The site will be used for the supply of licensed commercial products and to complement its clinical manufacturing facility
You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing

The changing landscape of clinical trial manufacturing

With regulation changes, the death of the blockbuster, focus on personalised medicines and less R&D spend than ever before, the clinical trial manufacturing landscape has undergone many changes. SCM Pharma’s Dianne Sharp reviews the sector and outlines what companies of the future could look like
Manufacturing

SCM supports BTG in Varisolve scale-up

CDMO has previously been providing clinical development consultancy for varicose vein treatment
Subscribe now